Literature DB >> 20671298

Effects of feeding bile acids and a bile acid sequestrant on hepatic bile acid composition in mice.

Youcai Zhang1, Curtis D Klaassen.   

Abstract

An improved ultra performance liquid chromatography-tandem mass spectrometry (UPLC/MS/MS) method was established for the simultaneous analysis of various bile acids (BA) and applied to investigate liver BA content in C57BL/6 mice fed 1% cholic acid (CA), 0.3% deoxycholic acid (DCA), 0.3% chenodeoxycholic acid (CDCA), 0.3% lithocholic acid (LCA), 3% ursodeoxycholic acid (UDCA), or 2% cholestyramine (resin). Results indicate that mice have a remarkable ability to maintain liver BA concentrations. The BA profiles in mouse livers were similar between CA and DCA feedings, as well as between CDCA and LCA feedings. The mRNA expression of Cytochrome P450 7a1 (Cyp7a1) was suppressed by all BA feedings, whereas Cyp7b1 was suppressed only by CA and UDCA feedings. Gender differences in liver BA composition were observed after feeding CA, DCA, CDCA, and LCA, but they were not prominent after feeding UDCA. Sulfation of CA and CDCA was found at the 7-OH position, and it was increased by feeding CA or CDCA more in male than female mice. In contrast, sulfation of LCA and taurolithocholic acid (TLCA) was female-predominant, and it was increased by feeding UDCA and LCA. In summary, the present systematic study on BA metabolism in mice will aid in interpreting BA-mediated gene regulation and hepatotoxicity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20671298      PMCID: PMC2952563          DOI: 10.1194/jlr.M007641

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  37 in total

1.  Human UDP-glucuronosyltransferase (UGT)1A3 enzyme conjugates chenodeoxycholic acid in the liver.

Authors:  Jocelyn Trottier; Mélanie Verreault; Susan Grepper; Didier Monté; Julie Bélanger; Jenny Kaeding; Patrick Caron; Ted T Inaba; Olivier Barbier
Journal:  Hepatology       Date:  2006-11       Impact factor: 17.425

2.  Bile acid metabolism in mammals. V. Studies on the sex difference in the response of the isolated perfused rat liver to chenodeoxycholic acid.

Authors:  I M Yousef; R Magnusson; V M Price; M M Fisher
Journal:  Can J Physiol Pharmacol       Date:  1973-06       Impact factor: 2.273

3.  Metabolism of iso-bile acids in the rat.

Authors:  S Shefer; G Salen; S Hauser; B Dayal; A K Batta
Journal:  J Biol Chem       Date:  1982-02-10       Impact factor: 5.157

Review 4.  Colesevelam hydrochloride: a novel bile acid-binding resin.

Authors:  M A Aldridge; M K Ito
Journal:  Ann Pharmacother       Date:  2001 Jul-Aug       Impact factor: 3.154

Review 5.  Nuclear receptors. I. Nuclear receptors and bile acid homeostasis.

Authors:  Bryan Goodwin; Steven A Kliewer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-06       Impact factor: 4.052

6.  Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid.

Authors:  Anna Glantz; Hanns-Ulrich Marschall; Frank Lammert; Lars-Ake Mattsson
Journal:  Hepatology       Date:  2005-12       Impact factor: 17.425

7.  Novel pathways of bile acid metabolism involving CYP3A4.

Authors:  Karl Bodin; Ulla Lindbom; Ulf Diczfalusy
Journal:  Biochim Biophys Acta       Date:  2005-02-21

8.  Hepatic 3 alpha-dehydrogenation and 7 alpha-hydroxylation of deoxycholic acid in the guinea-pig.

Authors:  A Cantafora; D Alvaro; A F Attili; A Di Biase; M Anza; A Mantovani; M Angelico
Journal:  Comp Biochem Physiol B       Date:  1986

9.  Why bile acid glucuronidation is a minor pathway for conjugation of endogenous bile acids in man.

Authors:  Alan F Hofmann
Journal:  Hepatology       Date:  2007-04       Impact factor: 17.425

Review 10.  Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics.

Authors:  A F Hofmann; L R Hagey
Journal:  Cell Mol Life Sci       Date:  2008-08       Impact factor: 9.261

View more
  68 in total

1.  Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity.

Authors:  Tiangang Li; Jessica M Francl; Shannon Boehme; Adrian Ochoa; Youcai Zhang; Curtis D Klaassen; Sandra K Erickson; John Y L Chiang
Journal:  J Biol Chem       Date:  2011-12-05       Impact factor: 5.157

2.  Bile Acid Signaling Is Involved in the Neurological Decline in a Murine Model of Acute Liver Failure.

Authors:  Matthew McMillin; Gabriel Frampton; Matthew Quinn; Samir Ashfaq; Mario de los Santos; Stephanie Grant; Sharon DeMorrow
Journal:  Am J Pathol       Date:  2015-12-09       Impact factor: 4.307

3.  Specific bile acids inhibit hepatic fatty acid uptake in mice.

Authors:  Biao Nie; Hyo Min Park; Melissa Kazantzis; Min Lin; Amy Henkin; Stephanie Ng; Sujin Song; Yuli Chen; Heather Tran; Robin Lai; Chris Her; Jacquelyn J Maher; Barry M Forman; Andreas Stahl
Journal:  Hepatology       Date:  2012-10       Impact factor: 17.425

4.  H1-antihistamines exacerbate high-fat diet-induced hepatic steatosis in wild-type but not in apolipoprotein E knockout mice.

Authors:  Vineesh V Raveendran; Karen M Kassel; Donald D Smith; James P Luyendyk; Kurt J Williams; Rachel Cherian; Gregory A Reed; Colleen A Flynn; Iván L Csanaky; Andrew L Lickteig; Matthew J Pratt-Hyatt; Curtis D Klaassen; Kottarappat N Dileepan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-05-22       Impact factor: 4.052

5.  Effect of various antibiotics on modulation of intestinal microbiota and bile acid profile in mice.

Authors:  Youcai Zhang; Pallavi B Limaye; Helen J Renaud; Curtis D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2014-03-20       Impact factor: 4.219

6.  Pharmacological Activation of PXR and CAR Downregulates Distinct Bile Acid-Metabolizing Intestinal Bacteria and Alters Bile Acid Homeostasis.

Authors:  Joseph L Dempsey; Dongfang Wang; Gunseli Siginir; Qiang Fei; Daniel Raftery; Haiwei Gu; Julia Yue Cui
Journal:  Toxicol Sci       Date:  2019-03-01       Impact factor: 4.849

7.  Berberine-induced Inactivation of Signal Transducer and Activator of Transcription 5 Signaling Promotes Male-specific Expression of a Bile Acid Uptake Transporter.

Authors:  Pengli Bu; Yuan Le; Yue Zhang; Youcai Zhang; Xingguo Cheng
Journal:  J Biol Chem       Date:  2017-02-01       Impact factor: 5.157

Review 8.  Characterization of animal models for primary sclerosing cholangitis (PSC).

Authors:  Peter Fickert; Marion J Pollheimer; Ulrich Beuers; Carolin Lackner; Gideon Hirschfield; Chantal Housset; Verena Keitel; Christoph Schramm; Hanns-Ulrich Marschall; Tom H Karlsen; Espen Melum; Arthur Kaser; Bertus Eksteen; Mario Strazzabosco; Michael Manns; Michael Trauner
Journal:  J Hepatol       Date:  2014-02-19       Impact factor: 25.083

9.  Effects of ablation and activation of Nrf2 on bile acid homeostasis in male mice.

Authors:  Youcai Zhang; Andrew J Lickteig; Jing Liu; Iván L Csanaky; Curtis D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2020-07-29       Impact factor: 4.219

10.  Bile acid supplementation improves established liver steatosis in obese mice independently of glucagon-like peptide-1 secretion.

Authors:  Pablo Quintero; Margarita Pizarro; Nancy Solís; Juan Pablo Arab; Oslando Padilla; Arnoldo Riquelme; Marco Arrese
Journal:  J Physiol Biochem       Date:  2014-05-10       Impact factor: 4.158

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.